We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids.
- Authors
Park, Jong-Chan; Jang, So-Yeong; Lee, Dongjoon; Lee, Jeongha; Kang, Uiryong; Chang, Hongjun; Kim, Haeng Jun; Han, Sun-Ho; Seo, Jinsoo; Choi, Murim; Lee, Dong Young; Byun, Min Soo; Yi, Dahyun; Cho, Kwang-Hyun; Mook-Jung, Inhee
- Abstract
Developing effective drugs for Alzheimer's disease (AD), the most common cause of dementia, has been difficult because of complicated pathogenesis. Here, we report an efficient, network-based drug-screening platform developed by integrating mathematical modeling and the pathological features of AD with human iPSC-derived cerebral organoids (iCOs), including CRISPR-Cas9-edited isogenic lines. We use 1300 organoids from 11 participants to build a high-content screening (HCS) system and test blood–brain barrier-permeable FDA-approved drugs. Our study provides a strategy for precision medicine through the convergence of mathematical modeling and a miniature pathological brain model using iCOs. Developing effective drugs for Alzheimer's disease (AD), the most common cause of dementia, has been difficult because of complicated pathogenesis. Here, the authors report an efficient network-based drug-screening platform developed by integrating mathematical modeling and the pathological features of human cerebral organoids.
- Subjects
ALZHEIMER'S disease; ORGANOIDS; DEMENTIA; DONEPEZIL; INDIVIDUALIZED medicine; TEST systems
- Publication
Nature Communications, 2021, Vol 12, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-020-20440-5